Hospital
RSSArticles
-
An Over-the-Counter Progestin-Only Pill Would Appeal to Millions
In a model based on a national survey of 2,539 reproductive-age women in the United States, an over-the-counter, progestin-only contraceptive pill would appeal to 12.5 million adults and 1.75 million teens, assuming there were no out-of-pocket costs.
-
Intervention Reduces Pregnancy and STI Risk Among Young Women with Depression
Young women with depression experience a higher rate of unintended pregnancy and sexually transmitted infections than young women, in general. The challenge for family planning clinicians is to find an effective intervention to help them prevent pregnancy and maintain their health.
-
Can COVID-19 Be Transmitted Sexually?
Researchers are beginning to investigate whether COVID-19 can be transmitted sexually. Early data from the study, as well as data from research in China, show the virus is present in some men’s semen. But other researchers who studied men who had recovered from COVID-19 did not find virus in semen samples. Authors of a new study hope to settle the question and answer questions about the transmissibility in semen.
-
Words and Phrases Related to Transgender Care
Researchers and organizations that advocate for the transgender and gender-diverse communities provide these words and definitions to educate people about the transgender community. They offer suggested sexual health language that is respectful of transgender and gender-diverse patients.
-
Clinicians Can Follow Recommendations to Better Serve Transgender Populations
Family planning clinicians and obstetrician/gynecologists likely will see transgender or gender-diverse patients seeking contraceptive care. Clinicians should learn more about transgender and gender-diverse patients to better inform their care of these populations.
-
Guidance Helps Clinicians Counsel Transgender Patients on Contraception
One of the challenges facing family planning clinics and obstetricians/gynecologists when serving transgender and gender-diverse patients is the lack of research and evidence-based guidelines to inform their clinical decisions. More research is needed about contraceptive needs and health effects on transgender and gender-diverse people, experts say.
-
Biometrics Expert Discusses Data Integrity for COVID-19 Clinical Trials
The first remdesivir double-blind, placebo-controlled clinical trial for treating COVID-19 was published recently in Lancet. A member of the trial’s data safety monitoring board is Weichung Shih, PhD. Shih discussed the role of biostatisticians in protecting data integrity for clinical trials and the challenges during the COVID-19 pandemic.
-
Enhance Health Literacy Among Study Participants
IRBs can help improve health literacy among potential research participants using several tactics, including asking studies to use plain language in informed consent forms. IRBs can review informed consent and subject recruitment materials to ensure the study information is clear and adheres to regulatory requirements.
-
IRB Highlights Standardized and Effective Metrics Model
As IRBs and research programs increasingly seek IRBs of record and form reliance agreements, they will need to know whom to trust. IRBs also need their own performance data to share with sponsors, researchers, and others. The challenge is developing metrics that work and can be used by other IRBs for benchmarking purposes.
-
Court Rejects Challenge to Federal Price Transparency Rule
Plaintiffs announced intention to appeal decision.